Read the First Edition of The Lens, a new magazine by LSI arrow-icon
Learn More About Mazal Plant Pharmaceuticals
Mazal Plant Pharmaceuticals
Reports Graph
Developing healthier drugs from whole-plants. MAHDL, developed to elevate HDL-C, has undergone tests in man with positive results and has an IND from the FDA. Other whole-plant therapeutics are under development for dementia.
Technology/product details
Revenue projections
Capital raised to date
Growth strategy
CEO presentation
Competing Startups
More

Get a Demo and See the Full Profile

Get a demo today to see profiles of Spineology plus 6164 other startups.

Trusted By The Companies Pioneering What’s Next